AT124720B - Process for the production of water-soluble silicic acid-protein compounds. - Google Patents

Process for the production of water-soluble silicic acid-protein compounds.

Info

Publication number
AT124720B
AT124720B AT124720DA AT124720B AT 124720 B AT124720 B AT 124720B AT 124720D A AT124720D A AT 124720DA AT 124720 B AT124720 B AT 124720B
Authority
AT
Austria
Prior art keywords
water
production
silicic acid
soluble silicic
protein compounds
Prior art date
Application number
Other languages
German (de)
Inventor
Johann Abraham Von Wuelfing
Original Assignee
Johann Abraham Von Wuelfing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johann Abraham Von Wuelfing filed Critical Johann Abraham Von Wuelfing
Application granted granted Critical
Publication of AT124720B publication Critical patent/AT124720B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Compounds (AREA)

Description

  

   <Desc/Clms Page number 1> 
 
 EMI1.1 
 
 EMI1.2 
 Lactalbuminat und Natrimmetasilikat für therapeutyische Zwecke mit kolloidal löslicher Kieselsäure besteht hauptsächlich darin, das durch Auflösen von Casein bzw. Laetalbuminat in einer wässerigen Lösung von Natriummetasilikat erzeugte Produkt durch Eindampfen in eine trockene Form zu bringen, ohnedassdieWasserlöslichkeitundderkolloidaleZustandderKeselsätureindemPräparateverlorengehen. 



   Löst man   nämlich   Casein bzw. Laetalbuminat unter Zusatz der erforderlichen Menge   Natriunt-   metasilikats in Wasser, so erhält man eine fast neutrale bis schwach saure Lösung. Dampft man diese Lösung aber auf dem Wasserbade bei   90-100" C   zur Trockne, so löst sieh der   sepulverte   Rückstand   wohl noch leidlich   in heissem Wasser, die Kieselsäure hat aber den kolloidalen Zustand eingebüsst. Das zeigt sich dadurch, dass sie beim Stehen der Lösung ausflockt und sich am Boden als sandiges,   knirschendes   
 EMI1.3 
 Form   wertlos.   
 EMI1.4 
 mässige Verteilung der Komponenten gewährleistet ist. 



   Wenn man als Eiweissstoff von saurem Charakter an Stelle von Casein   ein   Albuminat. z. B. das aus   koagiuliertemLactalbumin durch starke Natronlauge gelöste   und durch verdünnte Salzsäure aus-   gefällte Produkt, verwenden will,   verfährt man ganz ähnlich wie bei   Anwendung'von C'asein. Jedoch   sind in dem Falle nur 3,5-3,7 Gewichtsteile Natriummetasilikat (Na2SiO3) auf 100 Gewichtsteile   Laetalbuminat   erforderlieh, um zu einem mit neutraler bis   schwach   saurer Reaktion in Wasser löslichen 
 EMI1.5 
 dem aus Casein und Natriummetasilikat erhaltenen ganz ähnlich. 

**WARNUNG** Ende DESC Feld kannt Anfang CLMS uberlappen**.



   <Desc / Clms Page number 1>
 
 EMI1.1
 
 EMI1.2
 Lactalbuminate and sodium metasilicate for therapeutic purposes with colloidally soluble silicic acid consists mainly of evaporating the product produced by dissolving casein or laetalbuminate in an aqueous solution of sodium metasilicate into a dry form, without the water solubility and the colloidal state of the kettle acid being lost.



   If one dissolves casein or laetalbuminate with the addition of the required amount of sodium metasilicate in water, an almost neutral to weakly acidic solution is obtained. If this solution is steamed to dryness on a water bath at 90-100 "C, the powdered residue will probably still dissolve reasonably in hot water, but the silica has lost its colloidal state. This is shown by the fact that it does so when the solution stands flocculates and appears on the ground as sandy, crunchy
 EMI1.3
 Form worthless.
 EMI1.4
 moderate distribution of the components is guaranteed.



   If one uses an albuminate instead of casein as a protein of acidic character. z. If, for example, you want to use the product dissolved from coagulated lactalbumin by strong sodium hydroxide solution and precipitated by dilute hydrochloric acid, the procedure is very similar to the application of casein. However, in this case only 3.5-3.7 parts by weight of sodium metasilicate (Na2SiO3) per 100 parts by weight of metalbuminate are required in order to produce a water-soluble solution with a neutral to weakly acidic reaction
 EMI1.5
 very similar to that obtained from casein and sodium metasilicate.

** WARNING ** End of DESC field may overlap beginning of CLMS **.

 

Claims (1)

PATENT-ANSPRUCH : Verfahren zur Herstellung von wasserlöslichen Kieselsäure-Eiweiss-Verbindungen in trockener haltbarer Form durch Losen von Eiweissstoffen sauren Charakters, wie Casein oder La@talbuuinaten, EMI1.6 Lösen der Eiweissstoffe in wässerigen Lösungen reinen Natriummetasilikats erhalten werden, bei möglichst niedriger Temperatur im Vakuum vorsichtig zur Trockne verdampft, den Rückstand mahlt und fein sieht. **WARNUNG** Ende CLMS Feld Kannt Anfang DESC uberlappen**. PATENT CLAIM: Process for the production of water-soluble silicic acid-protein compounds in dry, durable form by dissolving proteins of an acidic character, such as casein or la @ talbuuinaten, EMI1.6 Dissolving the protein substances in aqueous solutions of pure sodium metasilicate are obtained, carefully evaporated to dryness at the lowest possible temperature in a vacuum, the residue is ground and fine looks. ** WARNING ** End of CLMS field may overlap beginning of DESC **.
AT124720D 1927-01-27 1927-01-27 Process for the production of water-soluble silicic acid-protein compounds. AT124720B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT124720T 1927-01-27

Publications (1)

Publication Number Publication Date
AT124720B true AT124720B (en) 1931-10-10

Family

ID=3633979

Family Applications (1)

Application Number Title Priority Date Filing Date
AT124720D AT124720B (en) 1927-01-27 1927-01-27 Process for the production of water-soluble silicic acid-protein compounds.

Country Status (1)

Country Link
AT (1) AT124720B (en)

Similar Documents

Publication Publication Date Title
AT124720B (en) Process for the production of water-soluble silicic acid-protein compounds.
DE434633C (en) Process for the preparation of a Drosera extract which contains the active ferments and is particularly active in arteriosclerosis
DE728188C (en) Process for the preparation of concentrated solutions of diiodotyrosine
AT113466B (en) Process for the preparation of thelykinins.
AT96964B (en) Process for improving the taste of the alkali salts of dialkylbarbituric acids.
AT151319B (en) Artificial sausage casing.
AT102932B (en) Process for the production of moldings from alkali silicates.
AT133505B (en) Process for the preparation of ω-Oxyacylaminobenzolarsin- or -stibinoxden or ω-Oxyacylaminobenzolarsin- or -stibinsäuren.
AT233522B (en) Process for the production of permanently neutral chalk
DE413380C (en) Process for the preparation of pure 1-nitro-2-methylanthraquinone
CH123690A (en) Process for the preparation of the disodium salt of 4-iminomethylene sulphonic acid-2-auromercaptobenzene-1-sulphonic acid.
CH203606A (en) Process for the production of a new azo dye.
CH133702A (en) Process for the preparation of a new product which can be used as a dye.
CH151192A (en) Process for the preparation of 4-glycolylamino-3&#39;-amino-4&#39;-oxy-arsenobenzene.
CH357502A (en) Skin tanning agents
CH203603A (en) Process for the production of a new azo dye.
CH198323A (en) Process for the production of a new azo dye.
CH203607A (en) Process for the production of a new azo dye.
CH155026A (en) Process for the production of a new azo dye.
CH186728A (en) Process for the production of a preparation suitable for the production of matting baths.
CH145062A (en) Process for the preparation of a new, long-lasting, medically active salt of p-aminophenylstibic acid.
CH100317A (en) Process for the preparation of a connection between yeast and tannin.
CH96419A (en) Process for the production of a vat dye.
CH139069A (en) Process for the preparation of an oxythionaphthene.
CH150744A (en) Process for the preparation of a molecular compound of 2-phenylquinoline-4-carboxylic acid calcium with 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone.